KHALID HUBEISHY: Open Payments
NPI 1306930391 · FAIRPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$60,626 in 234 payments from 14 companies in 2025. Trend: 2023 $32,968 · 2024 $71,029 · 2025 $60,626
Honoraria: $29,425Speaker / faculty: $16,938Consulting: $6,400Food & beverage: $4,637Travel & lodging: $3,225
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 43 | $32,520 |
| Neurocrine BioSciences, Inc. | 57 | $21,198 |
| ABBVIE INC. | 36 | $5,102 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 38 | $680 |
| Teva Pharmaceuticals USA, Inc. | 17 | $231 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $216 |
| Janssen Pharmaceuticals, Inc | 3 | $173 |
| Alkermes, Inc. | 6 | $140 |
| Vanda Pharmaceuticals Inc. | 8 | $139 |
| Otsuka America Pharmaceutical, Inc. | 4 | $97 |
Products named: Auvelity, INGREZZA, VRAYLAR, CAPLYTA, AUSTEDO XR, TRINTELLIX, ARISTADA, HETLIOZ.
Industry payments across NY — which companies pay providers there.
